The firm’s expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customers’ brand loyalty, and evaluating brand strength and positioning.
It serves the life science, diagnostic and analytical instrument industries.
Clients include Agilent Technologies, Bruker, Eppendorf, Merck, Mettler Toledo, Millipore Sigma, PerkinElmer, Qiagen, Sciex, Thermo Fisher and Waters Corporation.
Craig Overpeck, CEO of BioInformatics, said over the next five to 10 years, it sees a world where instruments and diagnostics – including analytical, imaging, and clinical – will converge to lead a precision medicine revolution.
“We are putting a stake at the intersection of science, medicine, and technology to help guide companies with transformative information and media products and services for converging markets that will make a difference in the lives of billions of people for the next century.”
The Virginia Economic Development Partnership (VEDP) will support job creation.
Governor Ralph Northam said: “Virginia’s life sciences industry is leading the charge in cutting-edge technology and research, thanks to impressive companies like BioInformatics.
“This important sector is a significant contributor to the Commonwealth’s economy, and we are honored that BioInformatics has chosen to invest in its critical research operation and double its workforce in Northern Virginia.”
Libby Garvey, Arlington County Board member, said it was ‘thrilled’ the company is expanding its workforce.
“It’s companies like BioInformatics – companies looking for a highly-educated workforce, accessibility and resources – that are truly making Arlington a real leader in the tech industry.”